Between 30-50% of adults with hypertension have OSA, and this number increases to between 70-80% in adults with resistant hypertension. Additionally, untreated moderate-to-severe OSA increases the ...

SARASOTA, FL, Jan. 08, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: SILO) (“Silo” or the “Company”), a developmental stage ...

Data from the largest US Lyme disease registry suggests that 90% of PLD patients are excluded from clinical trials.

Fexlamose is being developed as a chronic treatment for COPD and asthma in conjunction with standard therapies, to improve ...

ActiGraph, which makes digital tools used in clinical trials, acquired the life sciences business of Biofourmis, once ...

As the curtain closed on 2024, FDA issued a new draft guidance to assist clinical trial sponsors, investigators, and institutional review ...

The company announced that the first subjects have been dosed in a Phase-1 clinical trial of SUVN-I6107 in the USA.

Suven Life Sciences surged 9.51% to Rs 138.70 after the firm dosed first subjects in a Phase-1 clinical trial of SUVN-I6107 being conducted in USA under FDA acceptance of investigational new drug (IND ...

Expected readouts in diabetes, cancer and depression headline a series of study results that could help the biotechnology ...

Over 300 Participants Have Completed Cumulative Six Months of Cytisinicline Treatment in the ORCA-OL Trial, Completing the Long-Term Exposure ...

QPS Holdings, a contract research organization with offices in the U.S., Asia and Europe, has named Ryght AI its ...